Taste Assessment of Maxalt Oral Disintegrating Tablets in Children - Trial 2011-002349-36

Name: Clinical Trial 2011-002349-36
Creator: Merck & Co., Inc.
Keywords: Migraine, clinical trial

Access comprehensive clinical trial information for 2011-002349-36 through Pure Global AI's free database. This phase not specified trial is sponsored by Merck & Co., Inc. and is currently status unknown. The study focuses on Migraine.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database

840K+ Trials

2011-002349-36

Trial Details

EU Clinical Trials Register • 2011-002349-36

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Taste Assessment of Maxalt Oral Disintegrating Tablets in Children

Study Focus

Disease/Condition

Migraine

Sponsor & Location

Primary Sponsor

Merck & Co., Inc.

Timeline & Enrollment

Phase

N/A

Start Date

N/A

End Date

N/A

Primary Outcome

a. Subject or parent/legal guardian, is, in the opinion of the investigator, mentally incapacitated.

ICD-10 Classifications

Migraine

Other migraine

Migraine, unspecified

Complicated migraine

Headache

Data Source

Registry

EU Clinical Trials Register

Trial ID

2011-002349-36

Type

Non-Device Trial